Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Not Confirmed
Not Confirmed
04-05 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Industry Trade Show
Not Confirmed
04-05 June, 2026
Digital content

01 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-appoints-accomplished-oncology-expert-steffen-heeger-md-msc-as-chief-medical-officer-to-drive-rejuvenated-pipeline-development-302786574.html

01 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-presents-new-radiochemistry-data-at-snmmi-2026-demonstrating-that-car-optimization-improves-tumor-targeting-and-pharmacokinetics-of-actinium-225-radioconjugates-302786571.html

30 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-to-present-atnm-400-program-update-at-snmmi-2026-conference-on-may-31-june-2-and-provides-nyse-american-listing-standards-notice-302786103.html

30 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-receives-two-patent-allowances-spanning-its-actimab-a-and-iomab-act-programs-302786081.html

06 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-three-snmmi-2026-presentations-highlighting-differentiated-profile-of-atnm-400-across-lung-and-prostate-cancer-and-radioconjugate-optimization-302763533.html

22 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-announces-compelling-pan-tumor-data-for-atnm-400-demonstrating-broad-efficacy-across-prostate-lung-and-breast-cancer-models-at-the-2026-american-association-of-cancer-research-annual-meeting-302749720.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE